Hyperthermia therapy
Posted: Jul 22, 2010 |Comments: 0
|
Mechanism
Hyperthermia may kill or weaken tumor cells, and is controlled to limit effects on healthy cells. Tumor cells, with a disorganized and compact vascular structure, have difficulty dissipating heat. Hyperthermia may therefore cause cancerous cells to undergo apoptosis in direct response to applied heat, while healthy tissues can more easily maintain a normal temperature.
Even if the cancerous cells do not die outright, they may become more susceptible to ionizing radiation therapy or to certain chemotherapy drugs, which may allow such therapy to be given in smaller doses.
Intense heating will cause denaturation and coagulation of cellular proteins, rapidly killing cells within a tumour. More prolonged moderate heating to temperatures just a few degrees above normal can cause more subtle changes. A mild heat treatment combined with other stresses can cause cell death by apoptosis. There are many biochemical consequences to the heat shock response within in cell, including slowed cell division and increased sensitivity to ionizing radiation therapy.
Hyperthermia can kill cells directly, but its more important use is in combination with other treatments for cancer. Hyperthermia increases blood flow to the warmed area, perhaps doubling perfusion in tumors, while increasing perfusion in normal tissue by ten times or even more. This enhances the delivery of medications. Hyperthermia also increases oxygen delivery to the area, which may make radiation more likely to damage and kill cells, as well as preventing cells from repairing the damage induced during the radiation session.
Cancerous cells are not inherently more susceptible to the effects of heat. When compared in in vitro studies, normal cells and cancer cells show the same responses to heat. However, the vascular disorganization of a solid tumor results in an unfavorable microenvironment inside tumors. Consequently, the tumor cells are already stressed by low oxygen, higher than normal acid concentrations, and insufficient nutrients, and are thus significantly less able to tolerate the added stress of heat than a healthy cell in normal tissue.
Mild hyperthermia, which provides temperatures equal to that of a naturally high fever, may stimulate natural immunological attacks against the tumor, as part of a natural physiological response called thermotolerance.
Moderate hyperthermia, which heats cells in the range of 40 to 42 C, damages cells directly, in addition to making the cells radiosensitive and increasing the pore size to improve delivery of large-molecule chemotherapeutic and immunotherapeutic agents (molecular weight greater than 1,000 Daltons), such as monoclonal antibodies and liposome-encapsulated drugs. Cellular uptake of certain small molecule drugs is also increased. Most local and regional cancer treatments are in this temperature range.
Very high temperatures, above 50 C (122 F), are used for ablation (direct destruction) of some tumors. This generally involves inserting a metal tube directly into the tumor, and heating the tip until the tissue next to the tube has been killed.
Heat sources
There are many techniques by which heat may be delivered. Some of the most common involve the use of focused ultrasound (FUS or HIFU), infrared sauna, microwave heating, induction heating, magnetic hyperthermia, infusion of warmed liquids, or direct application of heat such as through sitting in a hot room or wrapping a patient in hot blankets.
Types
Local hyperthermia heats a very small area, usually the tumor itself. In some instances, the goal is to kill the tumor by "cooking" it, without damaging anything else. The heat may be created with microwave, radiofrequency, ultrasound energy or using magnetic hyperthermia. Depending on the location of the tumor, the heat may be applied to the surface of the body, inside normal body cavities, or deep in tissue through the use of needles or probes. One relatively common type is radiofrequency ablation of small tumors. This is easiest to achieve when the tumor is on a superficial part of the body, which is called superficial hyperthermia, or when needles or probes are inserted directly into the tumor, which is called interstitial hyperthermia.
Regional hyperthermia heats a larger part of the body, such as an entire organ or limb. Usually, the goal is to weaken cancer cells so that they are more likely to be killed by radiation and chemotherapeutic medications. This may use the same techniques as local hyperthermia treatment, or it may rely on blood perfusion. In blood perfusion, the patient's blood is removed from the body, heated up, and returned to blood vessels that lead directly through the desired body part. Normally, chemotherapy drugs are infused at the same time. One specialized type of this approach is continuous hyperthermic peritoneal perfusion (CHPP), which is used to treat difficult cancers within the peritoneal cavity (the abdomen), including primary peritoneal mesothelioma and stomach cancer. Hot chemotherapy drugs are pumped directly into the peritoneal cavity to kill the cancer cells.
Whole-body hyperthermia heats the entire body to temperatures of about 39 to 41 C. It is typically used to treat metastatic cancer (cancer that spread to many parts of the body). Techniques include infrared hyperthermia domes which include the whole body apart from the head, putting the patient in a very hot room, or wrapping the patient in hot, wet blankets.
Treatment
Moderate hyperthermia treatments usually maintain the temperature for about an hour or so.
The schedule for treatments depends on the effect desired. After being heated, cells develop resistance to heat, which persists for about three days and reduces the likelihood that they will die from direct cytotoxic effects of the heat. This suggests a maximum treatment schedule of about twice a week. However, if the desired goal is increased radiosensitivity in a poorly oxygenated tumor, rather than directly killing the cells, then application of heat with every radiation treatment is acceptable.
Controlling temperatures
One of the challenges in thermal therapy is delivering the appropriate amount of heat to the correct part of the patient's body. For this technique to be effective, the temperatures must be high enough, and the temperatures must by sustained long enough, to damage or kill the cancer cells. However, if the temperatures are too high, or if they are kept elevated for too long, then serious side effects, including death, can result. The smaller the place that is heated, and the shorter the treatment time, the lower the side effects.
To minimize damage to healthy tissue and other adverse effects, physicians carefully monitor the temperature of the affected area. The goal is to keep local temperatures under 44 C (111 F) to avoid damage to surrounding tissues, and the whole body temperatures under 42 C (108 F), which is the upper limit compatible with life. These temperatures compare to the normal human body temperature, taken internally, of about 37.6 C (99.6 F).
A great deal of current research focuses on precisely positioning heat-delivery devices (catheters, microwave and ultrasound applicators, etc.) using ultrasound or magnetic resonance imaging, as well as developing new types of nanoparticles that make them particularly efficient absorbers while offering little or no concerns about toxicity to other tissues. Clinicians also hope to use advanced imaging techniques to monitor heat treatments in real time; heat-induced changes in tissue are sometimes perceptible using these imaging instruments.
Adverse effects
External application of heat may cause blisters, which generally heal quickly, and burns, which do not. All techniques may result in pain or fatigue. Perfusion and moderate or high levels of hyperthermia can cause swelling, blood clots, and bleeding. Whole-body hyperthermia, which is the riskiest treatment, usually results in diarrhea, nausea, vomiting, fatigue, and other symptoms of sunstroke; it may also cause cardiovascular problems.
Effectiveness
By itself, hyperthermia is generally ineffective, with only small numbers of patients receiving lasting benefit. However, it may significantly increase the effectiveness of other treatments.
When combined with radiation, hyperthermia is particularly effective at increasing the damage to acidic, poorly oxygenated parts of a tumor, and cells that are preparing to divide. Hyperthermia treatment is most effective when provided at the same time, or within an hour, of the radiation.
Whole body hyperthermia cannot safely reach the temperatures necessary to improve the effectiveness of radiation, and thus is not used with radiation, but it may be useful for chemotherapy and immunotherapy.
History
The application of heat to treat certain conditions, including possible tumors, has a long history. Ancient Greeks, Romans, and Egyptians used heat to treat breast masses; this is still a recommended self-care treatment for breast engorgement. Medical practitioners in ancient India used regional and whole-body hyperthermia as treatments.
During the 19th century, tumor shrinkage after a high fever due to infection had been reported in a small number of cases. Typically, the reports documented the rare regression of a soft-tissue sarcoma after erysipelas (an acute streptococcus bacterial infection of the skin; a different presentation of an infection by "flesh-eating bacteria") was noted. Efforts to deliberately recreate this effect led to the development of Coley's toxin. A sustained high fever after induction of illness was considered critical to treatment success. This treatment is generally considered both less effective than modern treatments and, when it includes live bacteria, inappropriately dangerous.
Properly controlled clinical trials on deliberately induced hyperthermia began in the 1970s.
Future directions
Hyperthermia may be combined with gene therapy, particularly using the heat shock protein 70 promoter.
Two major technological challenges make hyperthermia therapy complicated: the ability to achieve a uniform temperature in a tumor, and the ability to precisely monitor the temperatures of both the tumor and the surrounding tissue. Advances in devices to deliver uniform levels of the precise amount of heat desired, and devices to measure the total dose of heat received, are hoped for.
See also
Thermotherapy, use of heat for treating other conditions
Photothermal Therapy, use of infrared radiation to treat cancer
Photodynamic therapy, which uses light but not heat
References
^ ^ a b c d e f g h i j k l m n o Carolyn Freeman; Halperin, Edward C.; Brady, Luther W.; David E. Wazer (2008). Perez and Brady's Principles and practice of radiation oncology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 637644. ISBN 0-7817-6369-X.
^ a b c d e f g h i j k l Dollinger, Malin (2008). Everyone's Guide to Cancer Therapy; Revised 5th Edition: How Cancer Is Diagnosed, Treated, and Managed Day to Day. Kansas City, MO: Andrews McMeel Publishing. pp. 98100. ISBN 0-7407-6857-3.
^ a b c d e Information from the U.S. National Cancer Institute
^ a b c Gian F. Baronzio (2006). Hyperthermia In Cancer Treatment: A Primer (Medical Intelligence Unit). Berlin: Springer. pp. Introduction (no page numbers). ISBN 0-387-33440-8.
External links
Information from the American Cancer Society
Transurethral Microwave Thermotherapy of the Prostate (TUMT) at eMedicine
Hyperthermia - Cancer therapy hots up article on physics.org
Categories: Cancer treatmentsHidden categories: Wikipedia articles incorporating text from the National Cancer Institute Dictionary of Cancer Terms
Hyperthermia may kill or weaken tumor cells, and is controlled to limit effects on healthy cells. Tumor cells, with a disorganized and compact vascular structure, have difficulty dissipating heat. Hyperthermia may therefore cause cancerous cells to undergo apoptosis in direct response to applied heat, while healthy tissues can more easily maintain a normal temperature.
Even if the cancerous cells do not die outright, they may become more susceptible to ionizing radiation therapy or to certain chemotherapy drugs, which may allow such therapy to be given in smaller doses.
Intense heating will cause denaturation and coagulation of cellular proteins, rapidly killing cells within a tumour. More prolonged moderate heating to temperatures just a few degrees above normal can cause more subtle changes. A mild heat treatment combined with other stresses can cause cell death by apoptosis. There are many biochemical consequences to the heat shock response within in cell, including slowed cell division and increased sensitivity to ionizing radiation therapy.
Hyperthermia can kill cells directly, but its more important use is in combination with other treatments for cancer. Hyperthermia increases blood flow to the warmed area, perhaps doubling perfusion in tumors, while increasing perfusion in normal tissue by ten times or even more. This enhances the delivery of medications. Hyperthermia also increases oxygen delivery to the area, which may make radiation more likely to damage and kill cells, as well as preventing cells from repairing the damage induced during the radiation session.
Cancerous cells are not inherently more susceptible to the effects of heat. When compared in in vitro studies, normal cells and cancer cells show the same responses to heat. However, the vascular disorganization of a solid tumor results in an unfavorable microenvironment inside tumors. Consequently, the tumor cells are already stressed by low oxygen, higher than normal acid concentrations, and insufficient nutrients, and are thus significantly less able to tolerate the added stress of heat than a healthy cell in normal tissue.
Mild hyperthermia, which provides temperatures equal to that of a naturally high fever, may stimulate natural immunological attacks against the tumor, as part of a natural physiological response called thermotolerance.
Moderate hyperthermia, which heats cells in the range of 40 to 42 C, damages cells directly, in addition to making the cells radiosensitive and increasing the pore size to improve delivery of large-molecule chemotherapeutic and immunotherapeutic agents (molecular weight greater than 1,000 Daltons), such as monoclonal antibodies and liposome-encapsulated drugs. Cellular uptake of certain small molecule drugs is also increased. Most local and regional cancer treatments are in this temperature range.
Very high temperatures, above 50 C (122 F), are used for ablation (direct destruction) of some tumors. This generally involves inserting a metal tube directly into the tumor, and heating the tip until the tissue next to the tube has been killed.
Heat sources
There are many techniques by which heat may be delivered. Some of the most common involve the use of focused ultrasound (FUS or HIFU), infrared sauna, microwave heating, induction heating, magnetic hyperthermia, infusion of warmed liquids, or direct application of heat such as through sitting in a hot room or wrapping a patient in hot blankets.
Types
Local hyperthermia heats a very small area, usually the tumor itself. In some instances, the goal is to kill the tumor by "cooking" it, without damaging anything else. The heat may be created with microwave, radiofrequency, ultrasound energy or using magnetic hyperthermia. Depending on the location of the tumor, the heat may be applied to the surface of the body, inside normal body cavities, or deep in tissue through the use of needles or probes. One relatively common type is radiofrequency ablation of small tumors. This is easiest to achieve when the tumor is on a superficial part of the body, which is called superficial hyperthermia, or when needles or probes are inserted directly into the tumor, which is called interstitial hyperthermia.
Whole-body hyperthermia heats the entire body to temperatures of about 39 to 41 C. It is typically used to treat metastatic cancer (cancer that spread to many parts of the body). Techniques include infrared hyperthermia domes which include the whole body apart from the head, putting the patient in a very hot room, or wrapping the patient in hot, wet blankets.
Treatment
Moderate hyperthermia treatments usually maintain the temperature for about an hour or so.
The schedule for treatments depends on the effect desired. After being heated, cells develop resistance to heat, which persists for about three days and reduces the likelihood that they will die from direct cytotoxic effects of the heat. This suggests a maximum treatment schedule of about twice a week. However, if the desired goal is increased radiosensitivity in a poorly oxygenated tumor, rather than directly killing the cells, then application of heat with every radiation treatment is acceptable.
Controlling temperatures
One of the challenges in thermal therapy is delivering the appropriate amount of heat to the correct part of the patient's body. For this technique to be effective, the temperatures must be high enough, and the temperatures must by sustained long enough, to damage or kill the cancer cells. However, if the temperatures are too high, or if they are kept elevated for too long, then serious side effects, including death, can result. The smaller the place that is heated, and the shorter the treatment time, the lower the side effects.
To minimize damage to healthy tissue and other adverse effects, physicians carefully monitor the temperature of the affected area. The goal is to keep local temperatures under 44 C (111 F) to avoid damage to surrounding tissues, and the whole body temperatures under 42 C (108 F), which is the upper limit compatible with life. These temperatures compare to the normal human body temperature, taken internally, of about 37.6 C (99.6 F).
A great deal of current research focuses on precisely positioning heat-delivery devices (catheters, microwave and ultrasound applicators, etc.) using ultrasound or magnetic resonance imaging, as well as developing new types of nanoparticles that make them particularly efficient absorbers while offering little or no concerns about toxicity to other tissues. Clinicians also hope to use advanced imaging techniques to monitor heat treatments in real time; heat-induced changes in tissue are sometimes perceptible using these imaging instruments.
Adverse effects
External application of heat may cause blisters, which generally heal quickly, and burns, which do not. All techniques may result in pain or fatigue. Perfusion and moderate or high levels of hyperthermia can cause swelling, blood clots, and bleeding. Whole-body hyperthermia, which is the riskiest treatment, usually results in diarrhea, nausea, vomiting, fatigue, and other symptoms of sunstroke; it may also cause cardiovascular problems.
Effectiveness
By itself, hyperthermia is generally ineffective, with only small numbers of patients receiving lasting benefit. However, it may significantly increase the effectiveness of other treatments.
When combined with radiation, hyperthermia is particularly effective at increasing the damage to acidic, poorly oxygenated parts of a tumor, and cells that are preparing to divide. Hyperthermia treatment is most effective when provided at the same time, or within an hour, of the radiation.
Whole body hyperthermia cannot safely reach the temperatures necessary to improve the effectiveness of radiation, and thus is not used with radiation, but it may be useful for chemotherapy and immunotherapy.
History
The application of heat to treat certain conditions, including possible tumors, has a long history. Ancient Greeks, Romans, and Egyptians used heat to treat breast masses; this is still a recommended self-care treatment for breast engorgement. Medical practitioners in ancient India used regional and whole-body hyperthermia as treatments.
During the 19th century, tumor shrinkage after a high fever due to infection had been reported in a small number of cases. Typically, the reports documented the rare regression of a soft-tissue sarcoma after erysipelas (an acute streptococcus bacterial infection of the skin; a different presentation of an infection by "flesh-eating bacteria") was noted. Efforts to deliberately recreate this effect led to the development of Coley's toxin. A sustained high fever after induction of illness was considered critical to treatment success. This treatment is generally considered both less effective than modern treatments and, when it includes live bacteria, inappropriately dangerous.
Properly controlled clinical trials on deliberately induced hyperthermia began in the 1970s.
Future directions
Hyperthermia may be combined with gene therapy, particularly using the heat shock protein 70 promoter.
Two major technological challenges make hyperthermia therapy complicated: the ability to achieve a uniform temperature in a tumor, and the ability to precisely monitor the temperatures of both the tumor and the surrounding tissue. Advances in devices to deliver uniform levels of the precise amount of heat desired, and devices to measure the total dose of heat received, are hoped for.
See also
Thermotherapy, use of heat for treating other conditions
Photothermal Therapy, use of infrared radiation to treat cancer
Photodynamic therapy, which uses light but not heat
References
^ ^ a b c d e f g h i j k l m n o Carolyn Freeman; Halperin, Edward C.; Brady, Luther W.; David E. Wazer (2008). Perez and Brady's Principles and practice of radiation oncology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 637644. ISBN 0-7817-6369-X.
^ a b c d e f g h i j k l Dollinger, Malin (2008). Everyone's Guide to Cancer Therapy; Revised 5th Edition: How Cancer Is Diagnosed, Treated, and Managed Day to Day. Kansas City, MO: Andrews McMeel Publishing. pp. 98100. ISBN 0-7407-6857-3.
^ a b c d e Information from the U.S. National Cancer Institute
^ a b c Gian F. Baronzio (2006). Hyperthermia In Cancer Treatment: A Primer (Medical Intelligence Unit). Berlin: Springer. pp. Introduction (no page numbers). ISBN 0-387-33440-8.
External links
Information from the American Cancer Society
Transurethral Microwave Thermotherapy of the Prostate (TUMT) at eMedicine
Hyperthermia - Cancer therapy hots up article on physics.org
Categories: Cancer treatmentsHidden categories: Wikipedia articles incorporating text from the National Cancer Institute Dictionary of Cancer Terms
Questions and Answers
The ailments listed are reported to us by satisfied customers with an indication of the products that they have used and are not claims made by us. The information in this document is for the sole use of registered FLP distributors and must not be used to solicit orders from the general public
financial crisis has conned everyone's live. Mass layoffs were happening in everywhere which is very sad. Throughout the crisis era not really a couple of companies go under. This will make the company managers searching for the best and accurate online marketing strategy to enhance the productivity and efficiency of the organization. The best online marketing strategy is really a way to succeed.
Business needs customers to make profit and survive. It's as simple as that. Without doing any marketing no-one knows you exist and you're not going to get too far. So, if you're in serious business, you have to get your message out.
Is your company on the lookout for a plush new office in London? If so there is plenty of different choice as regard areas and plenty of choice when it comes to office space, Lloyd's area of London being a prime example of what is on offer.
The Digital governors are designed not just to take control of the speed of the machine but it also allowed the machine to be smarter, allowing automation and improved functionality for the engine. By implementing these governors, the system became more stabilized and reliable, and there is no more need to add diesel generators that consume precious fuel and is expensive to maintain
If you're heading to Australia for business, you'll discover a world-class destination that's at the cutting edge of many industries. Australia is also ideally located for business opportunities in Asia, and it has a sturdy economy, exceptional facilities, good communication services and strong institutions.Here's just a brief introduction to the essentials for business travellers.
MotherParkers upgrade package thermal transfer coding coffee - heat transfer printing, coding and pa
Mother ParkersTea & Coffee Company for coffee bags packaging business increased by using several thermal transfer coding machine in order to clearly print the latest date
Intaglio process of pre-printed cardboard tissue paper - gravure printing, carton printing - the pri
At present, Europe and the United States and some other developed countries, the international total of 30% of corrugated containers were pre-printed with the new technology
2,3 months of this year, the printing and packaging listed companies have released results for 2009, annual report or newsletter. Interpretation of the six newspaper ticket printing, 烟标 printing
Experts on the selection of CNC machine tools - machine tools, CNC machine tools - machinery industr
1 choose CNC machine tools Principle A. If the optional stability and reliability of NC Machine tool Can not be stable and reliable work, it completely lost its meaning. Therefore
Purpose Mammals use this if they do not want to risk their own lives during unfavourable and/or environmental conditions
Discuss this Article
Author Box
Articles Categories
